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Abstract
Aim: Irritable Bowel Syndrome (IBS) is a chronic functional bowel condition, which has substantial impact on quality of life and use of healthcare
services. Patients often report using complementary and alternative medicine (CAM) for symptom management despite limited evidence to
support its use. Psychological factors have been shown to be important in both influencing CAM use and as avenues of intervention to assist
in managing IBS symptoms. Therefore, this review assessed prevalence of and psychological factors associated with CAM use by people
with IBS. Method: Five electronic databases (including AMED, EMBASE and PsychINFO) were searched for studies that examined both the
extent of and the reasons for CAM use. Five studies met the inclusion criteria. Results: Prevalence of CAM use ranged from 9% to 38%.
CAM use was associated with psychosocial factors, including concerns about conventional medical care (i.e., the perceived harmful effects
of medication, perception that conventional medicine had failed, and lack of satisfaction with conventional care) and anxiety. Conclusion:
These findings identify psychological factors associated with CAM use which could be targeted through psychologically oriented management
strategies for those affected with IBS.
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Introduction
Irritable bowel syndrome (IBS) is a chronic functional bowel disorder characterised by numerous episodic symptoms
including abdominal pain, constipation, diarrhoea, and abdominal bloating. Prevalence estimates range from 7 to
20% in western populations (Andrews et al., 2005; Grundmann & Yoon, 2010) with reported female predominance
in healthcare seeking (Andrews et al., 2005; Hungin, Chang, Locke, Dennis, & Barghout, 2005; Wilson, Roberts,
Roalfe, Bridge, & Singh, 2004). Many affected are frequent users of healthcare services (Talley, 2008) and may
be referred for potentially costly secondary consultations (Wilson et al., 2004). IBS contributes to lost working
hours and productivity (Dean et al., 2005; Hungin et al., 2005; Wilson et al., 2004) and impacts negatively on
multiple facets of quality of life including sleep, diet, sexual function, and travel (Amouretti et al., 2006; Dancey &
Backhouse, 1993; Dancey, Hutton-Young, Moye, & Devins, 2002; Faresjö et al., 2006; Lea & Whorwell, 2001).
Additionally, symptoms may result in significant emotional distress and those affected may “catastrophise” IBS
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symptoms as being indicative of a potentially life-threatening health condition (Lackner, Quigley, & Blanchard,
2004; Tanaka, Kanazawa, Fukudo, & Drossman, 2011). These issues highlight the need for effective treatment
for IBS.
The aetiology of IBS is not fully understood and is currently linked to a complex interplay of biological and
psychosocial factors (Tanaka et al., 2011). Consequently conventional medical treatment for IBS is often pharma-
cologically orientated towards symptom relief rather than directed towards potential aetiological factors (Chey,
Maneerattaporn, & Saad, 2011; Harris & Heitkemper, 2012a, 2012b). Nevertheless, conventional medical treatment
is frequently reported as unsatisfactory (Hayee & Forgacs, 2007) and considered limited given the scope of IBS
symptoms. Many opt to use complementary and alternative medicine (CAM) in an effort to manage symptoms
(Kong et al., 2005).
Complementary and Alternative Medicine Use in IBS
CAM includes primarily self-funded treatments or therapies that operate on different philosophical principles from
those of the biomedical model of conventional medicine (Zollman & Vickers, 1999). CAM’s prevalence for IBS
has been reported between 37 and 50% (Drossman et al., 2009; Kong et al., 2005; Langmead, Chitnis, & Rampton,
2002) with similar rates reported for inflammatory bowel disease (IBD) (Hilsden, Verhoef, Rasmussen, Porcino,
& DeBruyn, 2011; Langmead et al., 2002). Demographically, CAM-users are more likely to be female, have a
greater disposable income, higher educational attainment and chronic health conditions with prolonged symptom
discomfort (Astin, 1998; Bishop & Lewith, 2010; Metcalfe, Williams, McChesney, Patten, & Jetté, 2010; Talley,
Boyce, & Jones, 1997).
The prevalence of CAM use presents a number of issues for those who practise conventional medical treatment
of IBS. Firstly, CAM use may indicate that conventional medical care is not meeting patient treatment expectations,
which may consist of either real or perceived shortcomings in medical care (Drossman et al., 2009; Smart, Mayberry,
& Atkinson, 1986). Secondly, there is potential for harmful interactions between conventional pharmacologic
treatment and some forms of CAM (Leung, Shalansky, Lo, & Jadusingh, 2009; Shane-McWhorter & Geil, 2002;
Vincent & Furnham, 1997). Thirdly, many CAM treatments for IBS currently lack established efficacy (Ford et al.,
2008). In the UK, for example, National Institute for Health and Clinical Excellence’s guidelines for medical prac-
titioners do not recommend the use of acupuncture or reflexology in IBS patients (NICE, 2008). Clearly issues
with both conventional medical and CAM treatments exist. One further option for management of symptoms is to
incorporate psychological factors into treatment protocol.
The Role of Psychological Factors in IBS Management
The role of psychological factors in IBS has been emphasised by the lack of aetiological consensus and conjecture
that disturbance in the pathways between brain and gut results in IBS symptoms (Quigley, 2006). Evidence indicates
that psychological factors related to illness, such as perceptions about illness, are important as they may impact
on coping behaviours and quality of life (Hagger & Orbell, 2003; Rutter & Rutter, 2002), illness experience and
conventional healthcare seeking (Lea & Whorwell, 2004; van Dulmen, Fennis, Mokkink, & Bleijenberg, 1996; van
Dulmen, Fennis, Mokkink, van der Velden, & Bleijenberg, 1994, 1997).
Future healthcare seeking and anxiety have been shown to be reduced by following an intervention directed towards
changing specific components of illness perceptions (Oerlemans, van Cranenburgh, Herremans, Spreeuwenberg,
& van Dulmen, 2011; van Dulmen et al., 1996). Information-based interventions have demonstrated benefits in
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symptom and anxiety reduction and improvements in quality of life through enhanced feelings of control and un-
derstanding of IBS (Jarrett et al., 2009; Ringström et al., 2010; Robinson et al., 2006). Illness related anxiety may
also be reduced by giving a diagnosis of IBS (Hayee & Forgacs, 2007; Ilnyckyj, Graff, Blanchard, & Bernstein,
2003). Addressing such components could potentially be incorporated into conventional medical consultations to
aid effective management of IBS symptoms (e.g. van Dulmen et al., 1997).
Psychological Influences on CAM Use
Beliefs and perceptions related to illness, treatment and healthcare have been implicated as factors important in
CAM use. Concerns with efficacy of conventional medical treatment and dissatisfaction with doctor-patient com-
munication have influenced CAM use in general (Bishop, Yardley, & Lewith, 2006; Horne, Weinman, & Hankins,
1999) and gastro-intestinal (GI) populations (Hilsden, Scott, & Verhoef, 1998; Scott, Verhoef, & Hilsden, 2003).
General population studies have shown illness perceptions influence use of CAM (Bishop et al., 2006; Bishop,
Yardley, & Lewith, 2007; Searle & Murphy, 2000) and CAM-users have been shown to report worse health status
(Bishop & Lewith, 2010), and in those affected by IBS, poorer quality of life (van Tilburg et al., 2008) than those
not using CAM. CAM use may be further facilitated by a positive attitude towards CAM (Astin, 1998; Vincent &
Furnham, 1996). Similarly, when GI patients’ perceived benefits of CAM use (i.e. decreased stress, anxiety and
pain) outweigh perceived costs (i.e. financial outlay) CAM use is more likely (Giese, 2000). These findings suggest
CAM-users may report differing beliefs and perceptions compared to those not using CAM. Therefore, synthesis
of existing findings regarding influences on CAM use in IBSmay be used to inform the practitioner-client consultation
and direct the development of psychological components of management strategies for this complex and often
intractable condition.
Aim of the Review
The aims of the review were to quantify the extent of CAM use and explore psychological factors associated with
CAM uptake in those affected by IBS.
Method
Search Strategy
Electronic searches were conducted for articles published from 1978 onwards, when the Manning diagnostic cri-
teria were published (Manning, Thompson, Heaton, & Morris, 1978). Five electronic databases were searched to
identify studies that examined the prevalence of and factors that influence CAM use in IBS. These included AMED,
EMBASE, Cinahl, PubMed, and PsychINFO databases. The Cochrane database for systematic reviews was also
searched. Searching was conducted using the terms “irritable bowel syndrome”, “complementary” and “alternative”.
Further searches were carried out using the terms “functional gastrointestinal” and “functional bowel” in conjunction
with the terms previously listed. Search terms are listed in Figure 1.
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Figure 1. Review search terms and strategy.
Selection Process and Data Analysis
One researcher (LU) conducted initial searches and selection of abstracts. Duplicates were removed from the
search and all abstracts subsequently read. Where it was unclear if a study fitted the review criteria, the full text
was obtained. There were two main inclusion criteria. Firstly, studies had to include measurement regarding the
extent of CAM use in IBS. Secondly, included studies needed to have examined psychological factors that influence
CAM use in those affected by IBS (such as beliefs about treatment for IBS). No restrictions were placed on the
type of analysis or design studies used and only studies published in English were included. Studies that focused
exclusively on conventional care seeking or organic bowel conditions were excluded from the review. Reference
lists of obtained articles were also checked for relevant studies. Two researchers (KM & PF), then cross-validated
the final selection of studies from the 13 full text articles down to the final five that were included. Agreement to
include the studies amongst the three researchers was unanimous. The process of identification of studies is
presented in Figure 2.
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Figure 2. Flow chart showing the process of identifying relevant studies.
Results
Five studies met the inclusion criteria. Studies were conducted in the UK (Smart et al., 1986), Holland (Donker,
Foets, & Spreeuwenberg, 1999), Canada (Verhoef, Sutherland, & Brkich, 1990), Australia (Koloski, Talley, Huskic,
& Boyce, 2003) and the US (van Tilburg et al., 2008). Four studies used a survey/questionnaire design and one
(Donker et al., 1999) used quantifiable structured interviews. A summary of findings is provided in Table 1.
Included studies focused on participants with a functional bowel disorder (FBD, referring to IBS) or made sole
reference to IBS. Recruitment and data collection varied from postal questionnaires (Smart et al., 1986), to recruit-
ment from a general practitioner clinic (Donker et al., 1999) and outpatient clinic (Smart et al., 1986; Verhoef et
al., 1990). Two studies used data collected from previous work by the respective authors, for example from a
previous healthcare survey for those with FBD (van Tilburg et al., 2008), and previous population surveys (Koloski
et al., 2003). The studies reported female predominance in samples, ranging from 60 to 75%.
Study Methodologies
All studies examined group differences. Two studies (van Tilburg et al., 2008; Verhoef et al., 1990) used one
group of IBS/FBD outpatients and analysed participants in terms of those who had used or not used CAM. Smart
et al. (1986) compared 96 IBS patients to 143 patients with other unspecified organic upper GI disorders and 222
Crohn’s disease patients. Donker et al. (1999) and Koloski et al. (2003) compared an IBS group to healthy controls
in addition to healthcare (including alternative healthcare) consulters and non-consulters.
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Table 1
Summary of Studies Included in the Review
Reasons for CAM useExtent of CAM useOutcomesDiagnosis of IBSParticipants
First
author,
Year,
Country
CAM use significantly more likely if
conventional treatment “had failed”
in those with IBS.
CAM use: IBS (11%); GI
(4%); Crohn’s (6%).
Consulted CAM
Questionnaire –
practices and
practitioners. No. of
IBS - Manning et al.
(1978).
n = 96 IBS patients
(n = 67 female); n
=143 organic GI (n
Smart et
al. (1986)
(UK)
practitioner: IBS (16%);
GI (2%); Crohn’s (6%).
treatments, treatment
options.
= 84 female); n =
222Crohn’s disease
(n = 137 female).
CAM-users significantly less
satisfied with conventional treatment
50% of CAM-users had
functional diagnoses
CAMuse and scepticism
towards conventional
medicine index.
Gastroenterologist
consensus scale 1
(functional) – 5
(organic).
n = 395 GI adult
outpatients (n = 237
female) (n = 63
Functional
diagnosis)
Verhoef et
al. (1990)
(Canada) (54% vs. 85% non-users); had more
stressful life events in previous year
(70% vs. 47%); more sceptical of
(13% of non users). 41%
of CAM use not for
bowel disorder but other
health issue. conventional medicine (49% vs.
13%) and less satisfied with
conventional practitioner answers
(77% vs. 91%).
IBS patients had significantly poorer
health (and “other” complaints);
32% of those with IBS
consulted CAM
Questionnaire –
experienced health;
Diagnosed prior to
study.
n = 10787 GP
registered (age 15+,
Donker et
al. (1999)
(Holland) higher GHQ and BIOPRO scores
compared to population group.
practitioner (15%
non-IBS).
GHQ (30); no. of
complaints (14 days
51% female) n = 53
(n = 37 female) IBS
prior); BIOPRO scale (n
= 53 interviews).
patients via General
practice.
Females significantly more likely to
use CAM in contrast to greater pain
86.5% functional GI
group sought
Healthcare seeking SSI;
symptom status;
Psychological morbidity.
Abdominal pain > 1
month; Rome I
criteria. IBS or
n = 207 IBS/FD
patients (n = 143
female); n = 100
Koloski et
al. (2003)
(Australia) and perception of symptomsconventional healthcare.
functional
dyspepsia.
controls (no.
symptoms – not
predicting conventional care
seeking.
20.8% had sought
alternative healthcare.
included in all
analyses).
9% had used CAM in
previous 12 months.
Factors that predicted CAM use
were being female, higher education
CAM use was 35% over
past three months in
Set of questionnaires
including: symptom
Patient index cards
screened to
n = 1012 patients
with IBS or other
van
Tilburg et
level and higher anxiety (BSI).FBD, 38% in IBS; ginger,severity (IBS-SS);determine IBS orfunctional diagnosisal. (2008)
(US) Dissatisfaction with conventionalmassage and yoga wereQuality of life (IBS-QOL);other functional
diagnosis.
(n = 248 male).
CAM-users and care and perception of lack ofthe most popular CAM
treatments.
Psychological distress
(Brief symptom inventorynon-CAM users
compared.
effectiveness of prescription
medication were not associated with
CAM use.
– BSI); Ratings of
perceived effectiveness
of treatment.
Note. BIOPRO = Biographical list of problems; BSI = Brief Symptom Inventory; GHQ = General Health Questionnaire; IBS-QOL = Irritable
Bowel Syndrome Quality of Life; IBS-SS = IBS symptom severity scale; SSI = Semi-structured interview.
Smart et al. (1986) assessed the frequency of CAM use in patients with a diagnosis of IBS according to the
Manning criteria (Manning et al., 1978) and for whom a clinical examination revealed no bowel abnormalities.
Patients with organic GI disorders were recruited from the same outpatient clinic as those with IBS and Crohn’s
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patients were contacted via post. All participants completed a questionnaire on alternative medicine consultations.
Verhoef et al. (1990) however, examined patients who sought alternative treatment for the problem which had
required a consultation with a GI specialist in the past two years. Differences in demographic profile and health
status between CAM users and non-users were compared. Of the 395 GI patients recruited, 55 were classified
as having a functional GI disorder with diagnosis made by four GI specialists. This study excluded patients who
used CAM for health problems other than their diagnosed GI disorders. Participants completed a three item index
based on scepticism towards conventional medicine and were asked about alternative medicine use during the
previous two years.
Donker et al. (1999) focused on the health status of 53 patients with IBS recruited from general practices particip-
ating in the Dutch National Survey of Morbidity and Intervention in General Practice and compared their use of
healthcare services including CAM to a population sample of 10787. Participants were asked about healthcare
use, health problems in the two weeks prior to being questioned and completed the General Health Questionnaire
(GHQ) a screening tool for psychiatric illness (Goldberg, 1972) and the biographic problem list (BIOPRO) which
measured social problems (Hosman, 1983). Health related behaviour (e.g., smoking, exercise) and the amount
of healthcare sought was also measured which ranged from seeing a doctor (previous three months), a physical
therapist (previous 12 months), a specialist (last two years) and an alternative therapist (previous five years).
Using semi-structured interviews and questionnaires, Koloski et al. (2003) considered usage of both conventional
and alternative healthcare in 207 patients with functional GI diagnoses (IBS or functional dyspepsia). Participants
were recruited from one of two previous surveys carried out by the authors and separated into consulters or non-
consulters for both conventional and alternative healthcare. Participants were asked about frequency, access and
satisfaction with healthcare. The structured interview for bowel symptoms was administered to give a functional
diagnosis based on the Rome I criteria (Drossman et al., 1994). This structured interview also accounted for aspects
related to quality of life and extent of symptoms. In addition, participants were given the Composite International
Diagnostic Interview (World Health Organization, 1997) designed to assess past and current psychological dis-
turbance.
Using data from 1012 FBD patients recruited from an “outpatient” healthcare maintenance organisation in a pre-
vious study (Nyrop et al., 2007), van Tilburg et al. (2008) examined CAM use in IBS and FBD. Participants were
assessed for symptom severity at a “baseline” visit to the clinic with the Irritable Bowel Syndrome Severity Scale
(IBS-SS) (Francis, Morris, & Whorwell, 1997), quality of life using the Irritable Bowel Syndrome Quality of Life
scale, IBS-QOL (Patrick et al., 1998), psychological distress using the Brief Symptom inventory (BSI) (Derogatis,
1993), perceived treatment effectiveness, and CAM use.
Extent of CAM Use
The reviewed studies indicated CAM use at between 9 and 38.4%. Smart et al. (1986) found significantly more
of those with IBS had visited an alternative practitioner compared to Crohn’s and organic GI patients. Current al-
ternative medicine use was significantly greater in the IBS group and herbal treatments and homeopathy were
usedmost frequently (Smart et al., 1986). Verhoef et al. (1990) reported that 50% of CAM-users had FBD (compared
to 13% of non-CAM users) and 9% used CAM for the condition they presented to a gastroenterologist. Chiropractors
(for conditions other than GI), herbalists, naturopaths and reflexologists were that most frequently CAM practitioners
and 46% of participants had visited more than one type of CAM practitioner.
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Donker et al. (1999) found the IBS patient group had paid significantly more visits to an alternative practitioner
than the population group (32% compared with 15%). Koloski et al. (2003) revealed that 86.5% of the functional
GI group had sought conventional healthcare at some point, and a reported 20.8% of participants had sought al-
ternative healthcare, with only 9% using any CAM in the previous 12 months. The most frequently accessed
treatment was naturopathy. Van Tilburg et al. (2008) found 35% of those with FBD and 38.4% of those with IBS
had used CAM with ginger, massage therapy and yoga being the most frequently used treatments.
Reasons for CAM Use
Demographics and Functional Diagnosis— Koloski et al. (2003) found 88.4% of the 20.8% of CAM users were
female. However, 79.8% of participants (64%who were female) did not use alternative healthcare. Neither Donker
et al. (1999), Smart et al. (1986) or Verhoef et al. (1990) specifically examined the role of gender although Donker
et al. (1999) reported that a majority of IBS patients were female. Van Tilburg et al. (2008) found being female
and higher educational attainment predicted CAM use. Verhoef et al. (1990) reported that a functional diagnosis
was an independent predictor of CAM use compared to those with organic GI disorders. Similarly, Smart et al.
(1986) reported more patients with IBS than Crohn’s used CAM.
Perception of Symptoms — Donker et al. (1999) found significantly more IBS outpatients used CAM than the
population group and those with IBS reported significantly more intense symptoms (e.g., abdominal pain and
“secondary” symptoms including tiredness, backache and headaches). Koloski et al. (2003) found that physical
symptoms of IBS significantly predicted conventional care seeking rather than CAM use. Van Tilburg et al. (2008)
found stronger perceptions of symptom severity were associated with CAM use but not when controlling for
demographics and other variables (e.g. the IBS-QOL and IBS-SS) in a logistic regression model.
Patient Perception of Conventional Treatment — Smart et al. (1986) found that the IBS group were more likely
to report using alternative treatments if they perceived conventional treatment had failed. Verhoef et al. (1990)
observed that 54% of CAM-users with GI disorders (including IBS) were satisfied with conventional treatment
compared with 85% of non-CAM participants and that GI patients who used CAMwere significantly more sceptical
(49%) of conventional medicine than those not using CAM (13%). Verhoef et al. (1990) also revealed associations
between a functional diagnosis and scepticism towards conventional medicine, and that these variables both (in-
dependently) significantly predicted the use of CAM. In relation to communication between conventional practitioner
and patient, CAM-users were less satisfied with responses from conventional practitioners than non-CAM users
(77% vs. 91%). Koloski et al. (2003) found dissatisfaction did not significantly influence CAM use, although there
was some difference between CAM-users and non-CAM users. Van Tilburg et al. (2008) found no association
between CAM use and satisfaction with physician care during their primary visit and that CAM-users did not rate
their conventional prescription medication as being less effective than non-CAM users.
Beliefs About CAMTreatments and Therapies—One study reported expectations of CAM efficacy as a rationale
for IBS patients to use CAM. Koloski et al. (2003) found a desire to treat the GI problem with a more natural ap-
proach, the potential for alternative treatments to work and personal recommendation were all factors (albeit not
significant) that appear to influence CAM use. Donker et al. (1999) reported that 92% of CAM-users felt CAM had
helped.
Other Psychosocial Factors — Verhoef et al. (1990) found stressful life events in the previous year significantly
predicted CAM use in those with FBD. Donker et al. (1999) reported that those with IBS had higher scores on the
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GHQ than the population group. Differences were observed in the two groups’ BIOPRO scores where those with
IBS reported greater concerns about the future, lower self-confidence, fewer social interactions, and relationship
difficulties. The IBS group reported more occupational absence in the two months prior to the study. Additionally,
having IBS resulted in significantly more visits to the family GP, a physical therapist and a GI specialist. The sig-
nificant differences observed in healthcare seeking (including CAM use) between the two groups may be influenced
by such psychosocial factors (Donker et al., 1999). Koloski et al. (2003) observed differences, albeit not significant,
between both sets of healthcare consulters (CAM and conventional treatment) and non-consulters in psychological
disturbance and perception of symptoms. Van Tilburg et al. (2008) found CAM-users reported significantly poorer
IBS-QOL scores compared to those not using CAM. CAM-users also reported higher scores on the somatisation,
anxiety and depression subscales of the BSI. Logistic regression analysis revealed that anxiety was the sole
significant psychosocial predictor of CAM use.
Discussion
Prevalence of CAMwas lower than CAM use reported by Kong et al. (2005) and Langmead et al. (2002). However,
this might be explained by reviewed studies focusing on consultation with a CAM practitioner as opposed to self-
directed treatments (Kong et al., 2005). The reviewed studies included patient group and healthy control population
comparisons, in addition to comparisons of those with IBS who used CAM and those not using CAM. Findings
indicate that those with IBS who use CAM may report more severe symptoms and have concerns about conven-
tional medicine including unhappiness and dissatisfaction with conventional care.
Female predominance was evident, which is concurrent with what is known about IBS (e.g. Andrews et al., 2005),
however, in terms of CAM, there was limited agreement with findings from non-illness specific investigation into
CAM use. CAM use in general has been reported to have female predominance (e.g. Astin, 1998), although only
one reviewed study (van Tilburg et al., 2008) found that being female was an independent predictor of CAM use
in those with a functional GI diagnosis. It should be noted however that the reviewed studies had a predominantly
female representation which is consistent with previous findings that a greater proportion of females than males
seek healthcare for IBS/functional GI symptoms (Andrews et al., 2005; Hungin et al., 2005). It has yet to be ascer-
tained whether this disparity between males and females is due to biological or environmental distinctions related
to gender or might be explained by differences in healthcare seeking (Corazziari, 2004).
Although there has been limited examination of many psychological aspects in general populations of CAM-users,
points of contrast and similarity exist with what is currently known about possible psychological influences on
CAM use. Illness related perceptions, for example, were not found to be strong influences on CAM use. This is
in contrast to findings from Bishop et al. (2006) who found stronger perceived consequences of illness (from a
general population) predicted use of CAM. This finding may be more indicative of a lack of measurement of such
constructs. With illness perceptions being a key component for intervention in IBS (e.g. Oerlemans et al., 2011)
this represents one important aspect that could be addressed by future research. CAM-users however, reported
poorer quality of life and more severe symptoms, which concurs to an extent with Astin (1998) who established
CAM-users from a general population reported poorer health than those not using CAM. There are further simil-
arities in CAM-users affected by IBD who report amplified symptom perception and poorer quality of life (Hilsden
et al., 1998; Langmead et al., 2002; Scott et al., 2003). One study (Koloski et al., 2003) found increased perception
of IBS symptoms predicted conventional care seeking suggesting it worthwhile to investigate this further in relation
to use of CAM.
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Treatment related beliefs however, appeared more influential on CAM use than illness perceptions. For example,
findings showed a negative perception of conventional medical care influenced CAM use as did a desire to treat
GI symptoms with a more natural approach (Bishop et al., 2006; Vincent & Furnham, 1996). A degree of dissatis-
faction with conventional medicine also appears evident, as found by Scott et al. (2003) in IBD patients. However,
future research should clarify whether this is due to issues with conventional treatment itself and the healthcare
consultation, or both factors.
A major strength of this review is that it is the first to synthesise both prevalence estimates and evidence of why
people affected with IBS use CAM. Several psychological factors that have a role in influencing CAM use have
been highlighted. These findings may be beneficial in informing areas of potential intervention in conventional
medical consultations. The review further highlights the paucity of research in this important area, thus highlighting
the need for additional research that would aid understanding of influences on CAM use. This review has identified
specific areas of investigation that could be addressed by future research. This may include addressing specific
psychological components of illness and treatment beliefs and assessing potential influence of these factors on
CAM use in those affected by IBS. Furthermore, exploring aspects of the health practitioner-client relationship to
determine where dissatisfaction may arise could have potential benefits in targeting and implementing future im-
provements in healthcare.
Conversely this review has a number of limitations that need to be considered. Due to differences in sample size
and measures used in the selected studies, meta-analysis was not deemed appropriate due to variation in both
study design and reporting of findings. However, across the five reviewed studies, there were common themes
why those with IBS turn to CAM although the methodological variation in the studies makes generalisation of
findings problematic and potentially limited. Group comparisons in each study differed notably and it might be
suggested that a protocol of studying CAM-users compared with those not using CAM may be advantageous in
terms of explaining psychological influences on CAM use more precisely. There may also be benefit in examining
factors that pull people to different forms of CAM (Bishop et al., 2006) as findings suggested that CAM is, at least
partially, sometimes viewed as a single entity in terms of treatment. The reviewed studies were also conducted
in different countries where differences in healthcare service provision may exist in addition to cultural differences.
Furthermore, there was variation in participant numbers in each of the studies. Two studies for example (Donker
et al., 1999; Verhoef et al., 1990) had relatively small numbers of participants with IBS/FBD. There is some ambi-
guity concerning the scope of functional GI diagnosis (Verhoef et al., 1990) and if all participants had IBS or dif-
ferent functional diagnoses (such as functional dyspepsia) (Koloski et al., 2003).
It was notable that none of the reviewed studies considered emotional response to illness, something that is often
a concern in those with IBS (e.g. Tanaka et al., 2011). CAM use was however predicted by higher reported anxiety
in one study (van Tilburg et al., 2008) but it is unclear if anxiety was present pre or post-illness. The psychosocial
factors (e.g. BIOPRO responses) reported by Donker et al. (1999) in the IBS group warrant further investigation
as this particular study focused on a small group of those affected by IBS and a considerably larger population
group. Further longitudinal investigation may reveal the extent to which these factors influence CAM use and if
differences exist on such constructs between CAM-users and those not using CAM. Additionally, there were notable
differences in the measurement of symptom experience. Smart et al. (1986) did not consider symptom duration
important in predicting CAM use in IBS as more patients with IBS were currently using CAM than the Crohn’s
group (who have similar symptoms). Two studies (Donker et al., 1999; van Tilburg et al., 2008) considered the
severity of GI symptoms and one considered ratings of quality of life (van Tilburg et al., 2008). Verhoef et al. (1990)
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however, did not consider participants’ reported symptoms. Further investigation into perceived severity of IBS
symptoms is therefore warranted to determine if CAM-users report more severe IBS symptoms.
Furthermore in relation to concerns about conventional medical treatment, “failure” of (Smart et al., 1986) and
“dissatisfaction” with conventional treatment (Koloski et al., 2003) may reflect sub-dimensions of the same construct.
Both refer to treatment, the consultation or both. In the studies reviewed, measurement of these factors varied
considerably. Koloski et al. (2003) conducted a healthcare seeking interview while Smart et al. (1986) asked
specifically about failure of conventional treatment. Verhoef et al. (1990) assessed scepticism towards conventional
medicine. Van Tilburg et al. (2008) considered first healthcare visits and perceived effectiveness of prescription
medication. Moreover, four studies (Donker et al., 1999; Koloski et al., 2003; Smart et al., 1986; Verhoef et al.,
1990) focused solely on CAM consultations thus neglecting “off the shelf” products from the analysis. Clarification
of the nature of dissatisfaction and a more expansive inclusion of CAM, which would include self-purchased
treatments and consideration of different forms of CAM, are additional factors that could be addressed in future
research.
Conclusion and Implications
CAM’s use has been shown to be associated with psychological factors which could be targeted through psycho-
logically based management strategies for those affected with IBS. Such interventions may be beneficial in ad-
dressing negative symptom or treatment perceptions and emotional distress that may accompany IBS symptoms
(e.g. van Dulmen et al., 1996) in addition to focusing on providing information about IBS (e.g. Jarrett et al., 2009).
It is possible that CAM-users may initially benefit more from such intervention as evidence suggests those with
IBS using CAM report an amplified or more intense illness experience than those not using CAM. This may extend
to CAM-users reporting poorer quality of life despite using CAM although future longitudinal studies are required
to support this. The array of psychological factors identified by this review also suggests that the application of a
theoretical framework to future research may aid understanding and inform translation to practical interventions.
One such model, the common-sense model of illness representation (Leventhal, Brissette, & Leventhal, 2003)
has incorporated both illness perceptions and treatment beliefs (e.g. Bishop et al., 2006). This model has had
success in both exploration and translation of findings into practical change in illness perceptions resulting in be-
nefits to health (McAndrew et al., 2008).
Competing Interests
None of the authors has a conflict of interest to declare.
References
Note: * indicates studies included in the review.
Amouretti, M., Le Pen, C., Gaudin, A. F., Bommelaer, G., Frexinos, J., Ruszniewski, P., . . . Hasnaoui, A. (2006). Impact of
irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterologie Clinique et Biologique, 30(2),
241-246. doi:10.1016/S0399-8320(06)73160-8
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Complementary and Alternative Medicine Use in IBS 356
Andrews, E. B., Eaton, S. C., Hollis, K. A., Hopkins, J. S., Ameen, V., Hamm, L. R., . . . Mangel, A. W. (2005). Prevalence and
demographics of irritable bowel syndrome: Results from a large web-based survey.Alimentary Pharmacology & Therapeutics,
22(10), 935-942. doi:10.1111/j.1365-2036.2005.02671.x
Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of the American Medical
Association, 279(19), 1548-1553. doi:10.1001/jama.279.19.1548
Bishop, F. L., & Lewith, G. T. (2010). Who uses CAM? A narrative review of demographic characteristics and health factors
associated with CAM use.Evidence-Based Complementary and AlternativeMedicine, 7(1), 11-28. doi:10.1093/ecam/nen023
Bishop, F. L., Yardley, L., & Lewith, G. T. (2006). Why do people use different forms of complementary medicine? Multivariate
associations between treatment and illness beliefs and complementary medicine use. Psychology & Health, 21(5), 683-698.
doi:10.1080/14768320500444216
Bishop, F. L., Yardley, L., & Lewith, G. T. (2007). A systematic review of beliefs involved in the use of complementary and
alternative medicine. Journal of Health Psychology, 12(6), 851-867. doi:10.1177/1359105307082447
Chey, W. D., Maneerattaporn, M., & Saad, R. (2011). Pharmacologic and complementary and alternative medicine therapies
for irritable bowel syndrome. Gut and Liver, 5(3), 253-266. doi:10.5009/gnl.2011.5.3.253
Corazziari, E. (2004). Definition and epidemiology of functional gastrointestinal disorders. Best Practice & Research. Clinical
Gastroenterology, 18(4), 613-631. doi:10.1016/j.bpg.2004.04.012
Dancey, C. P., & Backhouse, S. (1993). Towards a better understanding of patients with irritable bowel syndrome. Journal of
Advanced Nursing, 18(9), 1443-1450. doi:10.1046/j.1365-2648.1993.18091443.x
Dancey, C. P., Hutton-Young, S. A., Moye, S., & Devins, G. M. (2002). Perceived stigma, illness intrusiveness and quality of
life in men and women with irritable bowel syndrome. Psychology Health and Medicine, 7(4), 381.
doi:10.1080/1354850021000015203
Dean, B. B., Aguilar, D., Barghout, V., Kahler, K. H., Frech, F., Groves, D., & Ofman, J. J. (2005). Impairment in work productivity
and health-related quality of life in patients with IBS. The American Journal of Managed Care, 11(Suppl.), S17-S26.
http://www.ajmc.com/
Derogatis, L. R. (1993). BSI Brief Symptom Inventory: Administration, scoring, and procedures manual (4th ed.). Minneapolis,
MN: National Computer Systems.
*Donker, G. A., Foets, M., & Spreeuwenberg, P. (1999). Patients with irritable bowel syndrome: Health status and use of health
care services. The British Journal of General Practice, 49(447), 787-792. http://www.ncbi.nlm.nih.gov/pmc/journals/261/
Drossman, D. A., Morris, C. B., Schneck, S., Hu, Y. J. B., Norton, N. J., Norton, W. F., & Bangdiwala, S. I. (2009). International
survey of patients with IBS: Symptom features and their severity, health status, treatments, and risk taking to achieve
clinical benefit. Journal of Clinical Gastroenterology, 43(6), 541-550. doi:10.1097/MCG.0b013e318189a7f9
Drossman, D. A., Richter, J. E., Talley, N. J., Corazziari, E., Thompson, W. G., & Whitehead, W. E. (1994). Functional
gastrointestinal disorders. Boston, MA: Little, Brown.
Faresjö, A., Anastasiou, F., Lionis, C., Johansson, S., Wallander, M.-A., & Faresjö, T. (2006). Health-related quality of life of
irritable bowel syndrome patients in different cultural settings. Health and Quality of Life Outcomes, 4, 21.
doi:10.1186/1477-7525-4-21
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Usher, Fox, Lafarge et al. 357
Ford, A. C., Talley, N. J., Spiegel, B. M. R., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M. M., & Moayyedi, P. (2008). Effect
of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: Systematic review and
meta-analysis. BMJ (Clinical Research Ed.), 337, a2313. doi:10.1136/bmj.a2313
Francis, C. Y., Morris, J., & Whorwell, P. J. (1997). The irritable bowel severity scoring system: A simple method of monitoring
irritable bowel syndrome and its progress. Alimentary Pharmacology & Therapeutics, 11(2), 395-402.
doi:10.1046/j.1365-2036.1997.142318000.x
Giese, L. A. (2000). A study of alternative health care use for gastrointestinal disorders. Gastroenterology Nursing, 23(1),
19-27. doi:10.1097/00001610-200001000-00005
Goldberg, D. (1972). The detection of psychiatric illness by questionnaire. London, England: Oxford University Press.
Grundmann, O., & Yoon, S. L. (2010). Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for
health-care practitioners. Journal of Gastroenterology and Hepatology, 25(4), 691-699. doi:10.1111/j.1440-1746.2009.06120.x
Hagger, M., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychology
& Health, 18(2), 141-184. doi:10.1080/088704403100081321
Harris, L. A., & Heitkemper, M. M. (2012a). Practical considerations for recognizing and managing severe irritable bowel
syndrome. Gastroenterology Nursing, 35(1), 12-21. doi:10.1097/SGA.0b013e31823ff0e8
Harris, L. A., & Heitkemper, M. M. (2012b). Practical considerations for recognizing and managing severe irritable bowel
syndrome (CE-Test). Gastroenterology Nursing, 35(1), 22-23. doi:10.1097/SGA.0b013e31823ff0e8
Hayee, B., & Forgacs, I. (2007). Psychological approach to managing irritable bowel syndrome. BMJ (Clinical Research Ed.),
334(7603), 1105-1109. doi:10.1136/bmj.39199.679236.AE
Hilsden, R. J., Scott, C. M., & Verhoef, M. J. (1998). Complementary medicine use by patients with inflammatory bowel disease.
The American Journal of Gastroenterology, 93(5), 697-701. doi:10.1111/j.1572-0241.1998.208_a.x
Hilsden, R. J., Verhoef, M. J., Rasmussen, H., Porcino, A., & DeBruyn, J. C. C. (2011). Use of complementary and alternative
medicine by patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 17(2), 655-662. doi:10.1002/ibd.21360
Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation
of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1-24.
doi:10.1080/08870449908407311
Hosman, C. (1983). Psychosocial problems and help seeking: A social–psychological study for preventive mental health care.
Lisse, Netherlands: Swets & Zeitlinger.
Hungin, A. P. S., Chang, L., Locke, G. R., Dennis, E. H., & Barghout, V. (2005). Irritable bowel syndrome in the United States:
Prevalence, symptom patterns and impact. Alimentary Pharmacology & Therapeutics, 21(11), 1365-1375.
doi:10.1111/j.1365-2036.2005.02463.x
Ilnyckyj, A., Graff, L. A., Blanchard, J. F., & Bernstein, C. N. (2003). Therapeutic value of a gastroenterology consultation in
irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 17(7), 871-880. doi:10.1046/j.1365-2036.2003.01523.x
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Complementary and Alternative Medicine Use in IBS 358
Jarrett, M. E., Cain, K. C., Burr, R. L., Hertig, V. L., Rosen, S. N., & Heitkemper, M. M. (2009). Comprehensive self-management
for irritable bowel syndrome: Randomized trial of in-person vs. combined in-person and telephone sessions. The American
Journal of Gastroenterology, 104(12), 3004-3014. doi:10.1038/ajg.2009.479
*Koloski, N. A., Talley, N. J., Huskic, S. S., & Boyce, P. M. (2003). Predictors of conventional and alternative health care
seeking for irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology & Therapeutics, 17(6), 841-851.
doi:10.1046/j.1365-2036.2003.01498.x
Kong, S. C., Hurlstone, D. P., Pocock, C. Y., Walkington, L. A., Farquharson, N. R., Bramble, M. G., . . . Sanders, D. (2005).
The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
Journal of Clinical Gastroenterology, 39(2), 138-141. doi:10.1097/01.mcg.0000155570.19340.61
Lackner, J. M., Quigley, B. M., & Blanchard, E. B. (2004). Depression and abdominal pain in IBS patients: The mediating role
of catastrophizing. Psychosomatic Medicine, 66(3), 435-441. doi:10.1097/01.psy.0000126195.82317.46
Langmead, L., Chitnis, M., & Rampton, D. S. (2002). Use of complementary therapies by patients with IBD may indicate
psychosocial distress. Inflammatory Bowel Diseases, 8(3), 174-179. doi:10.1097/00054725-200205000-00003
Lea, R., & Whorwell, P. J. (2001). Quality of life in irritable bowel syndrome. PharmacoEconomics, 19(6), 643-653.
doi:10.2165/00019053-200119060-00003
Lea, R., & Whorwell, P. J. (2004). Psychological influences on the irritable bowel syndrome. Minerva Medica, 95(5), 443-450.
http://www.minervamedica.it/en/journals/minerva-medica/index.php
Leung, V. W. Y., Shalansky, S. J., Lo, M. K., & Jadusingh, E. A. (2009). Prevalence of use and the risk of adverse effects
associated with complementary and alternative medicine in a cohort of patients receiving warfarin. The Annals of
Pharmacotherapy, 43(5), 875-881. doi:10.1345/aph.1L631
Leventhal, H., Brissette, I., & Leventhal, E. A. (2003). The common-sense model of self-regulation of health and illness. In L.
D. Cameron & H. Leventhal (Eds.), The self-regulation of health and illness behaviour (pp. 42-65). London, England:
Routledge.
Manning, A. P., Thompson, W. G., Heaton, K. W., & Morris, A. F. (1978). Towards positive diagnosis of the irritable bowel.
British Medical Journal, 2(6138), 653-654. doi:10.1136/bmj.2.6138.653
McAndrew, L. M., Musumeci-Szabó, T. J., Mora, P. A., Vileikyte, L., Burns, E., Halm, E. A., . . . Leventhal, H. (2008). Using
the common sense model to design interventions for the prevention and management of chronic illness threats: From
description to process. British Journal of Health Psychology, 13(2), 195-204. doi:10.1348/135910708X295604
Metcalfe, A., Williams, J., McChesney, J., Patten, S. B., & Jetté, N. (2010). Use of complementary and alternative medicine
by those with a chronic disease and the general population: Results of a national population based survey. BMC
Complementary and Alternative Medicine, 10, 58. doi:10.1186/1472-6882-10-58
National Institute of Clinical Excellence. (2008). Irritable bowel syndrome in adults (CG61): Diagnosis and management of
irritable bowel syndrome in primary care. London, England: National Institute for Health and Clinical Excellence.
Nyrop, K. A., Palsson, O. S., Levy, R. L., Korff, M. V., Feld, A. D., Turner, M. J., & Whitehead, W. E. (2007). Costs of health
care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Alimentary
Pharmacology & Therapeutics, 26(2), 237-248. doi:10.1111/j.1365-2036.2007.03370.x
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Usher, Fox, Lafarge et al. 359
Oerlemans, S., van Cranenburgh, O., Herremans, P.-J., Spreeuwenberg, P., & van Dulmen, S. (2011). Intervening on cognitions
and behavior in irritable bowel syndrome: A feasibility trial using PDAs. Journal of Psychosomatic Research, 70(3), 267-277.
doi:10.1016/j.jpsychores.2010.09.018
Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable
bowel syndrome: Development and validation of a new measure. Digestive Diseases and Sciences, 43(2), 400-411.
doi:10.1023/A:1018831127942
Quigley, E. M. M. (2006). Changing face of irritable bowel syndrome.World Journal of Gastroenterology: WJG, 12(1), 1-5.
http://www.wjgnet.com/1007-9327/
Ringström, G., Störsrud, S., Posserud, I., Lundqvist, S., Westman, B., & Simrén, M. (2010). Structured patient education is
superior to written information in the management of patients with irritable bowel syndrome: A randomized controlled study.
European Journal of Gastroenterology & Hepatology, 22(4), 420-428. doi:10.1097/MEG.0b013e3283333b61
Robinson, A., Lee, V., Kennedy, A., Middleton, L., Rogers, A., Thompson, D. G., & Reeves, D. (2006). A randomised controlled
trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut, 55(5), 643-648.
doi:10.1136/gut.2004.062901
Rutter, C. L., & Rutter, D. R. (2002). Illness representation, coping and outcome in irritable bowel syndrome (IBS). British
Journal of Health Psychology, 7(4), 377-391. doi:10.1348/135910702320645372
Scott, C. M., Verhoef, M. J., & Hilsden, R. J. (2003). Inflammatory bowel disease patients’ decisions to use complementary
therapies: Links to existing models of care. Complementary Therapies in Medicine, 11(1), 22-27.
http://www.journals.elsevier.com/complementary-therapies-in-medicine/doi:10.1016/S0965-2299(02)00107-3
Searle, A., & Murphy, S. (2000). Representations of illness: Their relationship with an understanding of and adherence to
homoeopathic treatment. Psychology Health and Medicine, 5(2), 179-191. doi:10.1080/713690179
Shane-McWhorter, L., & Geil, P. (2002). Interactions between complementary therapies or nutrition supplements and conventional
medications. Diabetes Spectrum, 15(4), 262-266. doi:10.2337/diaspect.15.4.262
*Smart, H. L., Mayberry, J. F., & Atkinson, M. (1986). Alternative medicine consultations and remedies in patients with the
irritable bowel syndrome. Gut, 27(7), 826-828. doi:10.1136/gut.27.7.826
Talley, N. J. (2008). Functional gastrointestinal disorders as a public health problem. Neurogastroenterology and Motility: The
Official Journal of the European Gastrointestinal Motility, 20(Suppl. s1), 121-129. doi:10.1111/j.1365-2982.2008.01097.x
Talley, N. J., Boyce, P. M., & Jones, M. (1997). Predictors of health care seeking for irritable bowel syndrome: A population
based study. Gut, 41(3), 394-398. doi:10.1136/gut.41.3.394
Tanaka, Y., Kanazawa, M., Fukudo, S., & Drossman, D. A. (2011). Biopsychosocial model of irritable bowel syndrome. Journal
of Neurogastroenterology and Motility, 17(2), 131-139. doi:10.5056/jnm.2011.17.2.131
van Dulmen, A. M., Fennis, J. F., Mokkink, H. G. A., & Bleijenberg, G. (1996). The relationship between complaint-related
cognitions in referred patients with irritable bowel syndrome and subsequent health care seeking behaviour in primary
care. Family Practice, 13(1), 12-17. doi:10.1093/fampra/13.1.12
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Complementary and Alternative Medicine Use in IBS 360
van Dulmen, A. M., Fennis, J. F., Mokkink, H. G. A., van der Velden, H. G., & Bleijenberg, G. (1994). Doctors’ perception of
patients’ cognitions and complaints in irritable bowel syndrome at an out-patient clinic. Journal of Psychosomatic Research,
38(6), 581-590. doi:10.1016/0022-3999(94)90055-8
van Dulmen, A. M., Fennis, J. F. M., Mokkink, H. G. A., van der Velden, H. G. M., & Bleijenberg, G. (1997). Persisting
improvement in complaint-related cognitions initiated during medical consultations in functional abdominal complaints.
Psychological Medicine, 27(3), 725-729. doi:10.1017/S0033291796003777
*van Tilburg, M. A. L., Palsson, O. S., Levy, R. L., Feld, A. D., Turner, M. J., Drossman, D. A., & Whitehead, W. E. (2008).
Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a
large HMO. BMC Complementary and Alternative Medicine, 8, 46. doi:10.1186/1472-6882-8-46
*Verhoef, M. J., Sutherland, L. R., & Brkich, L. (1990). Use of alternative medicine by patients attending a gastroenterology
clinic. CMAJ: Canadian Medical Association Journal, 142(2), 121-125.
Vincent, C., & Furnham, A. (1996). Why do patients turn to complementary medicine? An empirical study. The British Journal
of Clinical Psychology, 35(1), 37-48. doi:10.1111/j.2044-8260.1996.tb01160.x
Vincent, C., & Furnham, A. (1997). Complementary medicine: A research perspective. Chichester, England: John Wiley and
Sons.
Wilson, S., Roberts, L., Roalfe, A., Bridge, P., & Singh, S. (2004). Prevalence of irritable bowel syndrome: A community survey.
The British Journal of General Practice, 54(504), 495-502. http://www.rcgp.org.uk/Publications/BJGP.aspx
World Health Organization. (1997).Composite International Diagnostic Interview (CIDI), Core Version 2.1, Interviewer’s Manual.
Geneva, Switzerland: Author.
Zollman, C., & Vickers, A. (1999). What is complementary medicine? BMJ (Clinical Research Ed.), 319(7211), 693-696.
doi:10.1136/bmj.319.7211.693
PsychOpen is a publishing service by Leibniz Institute
for Psychology Information (ZPID), Trier, Germany.
www.zpid.de/en
Psychology, Community & Health
2013, Vol. 2(3), 346–361
doi:10.5964/pch.v2i3.65
Usher, Fox, Lafarge et al. 361
